Trust Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Sell
6,503
-79
-1% -$6.62K 0.04% 139
2026
Q1
$527K Hold
6,582
0.04% 139
2025
Q4
$561K Sell
6,582
-243
-4% -$19.9K 0.04% 133
2025
Q3
$531K Hold
6,825
0.04% 140
2025
Q2
$534K Hold
6,825
0.04% 136
2025
Q1
$495K Sell
6,825
-372
-5% -$26.6K 0.04% 136
2024
Q4
$533K Hold
7,197
0.04% 134
2024
Q3
$475K Hold
7,197
0.04% 143
2024
Q2
$665K Hold
7,197
0.06% 111
2024
Q1
$688K Hold
7,197
0.06% 111
2023
Q4
$549K Hold
7,197
0.05% 121
2023
Q3
$499K Hold
7,197
0.05% 116
2023
Q2
$679K Hold
7,197
0.07% 98
2023
Q1
$595K Buy
7,197
+212
+3% +$16.7K 0.07% 99
2022
Q4
$521K Hold
6,985
0.06% 109
2022
Q3
$577K Buy
6,985
+474
+7% +$45.6K 0.08% 96
2022
Q2
$619K Buy
6,511
+229
+4% +$23.7K 0.09% 92
2022
Q1
$740K Buy
6,282
+231
+4% +$25.9K 0.09% 87
2021
Q4
$784K Hold
6,051
0.1% 88
2021
Q3
$685K Sell
6,051
-241
-4% -$27.5K 0.09% 93
2021
Q2
$652K Buy
6,292
+622
+11% +$58.6K 0.09% 90
2021
Q1
$474K Buy
5,670
+889
+19% +$75.2K 0.06% 105
2020
Q4
$436K Buy
4,781
+979
+26% +$81.2K 0.07% 93
2020
Q3
$303K Buy
+3,802
New +$297K 0.05% 86

Other funds holding EW

Trust Asset Management's EW Position: Q2 2026 in Review

Trust Asset Management reduced its Edwards Lifesciences (EW) stake by 1.2% in Q2 2026, selling an estimated $6.62K and leaving 6,503 shares worth $588K. The position accounts for 0.04% of the portfolio, ranked #139.

Trust Asset Management first reported a position in EW in Q3 2020 and has held it in 24 quarters since. The position peaked at $784K in Q4 2021. 265 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Trust Asset Management held 6,503 shares of Edwards Lifesciences worth $588K as of Q2 2026.
  • Trust Asset Management sold 79 Edwards Lifesciences shares in Q2 2026, an estimated $6.62K.
  • Edwards Lifesciences made up 0.04% of Trust Asset Management's portfolio in Q2 2026, its #139 holding.
  • Trust Asset Management first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 24 quarters since.
  • Trust Asset Management's Edwards Lifesciences position peaked at $784K in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.